What are usually seen as 14 different mental health or neurodiversity conditions could really be five clusters of closely ...

Lumos Labs has gained US Food and Drug Administration (FDA) clearance for LumosityRx, a prescription digital therapeutic (PDT) that aims to improve attention span in adult patients with attention ...

LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.

"With LumosityRx, we're taking the core science and technology behind Lumosity and applying it to help people with ADHD, where attention is crucial to everyday life," said Dr. Bob Schafer, ...

HarmonEyes, the AI-driven eye-tracking software innovator, today announced the successful acquisition of iFocus Health, a clinically validated ADHD treatment monitoring solution that tracks eye ...

Children who returned to in-person school during the COVID-19 pandemic were far less likely to receive mental health ...

An independent review announced by the Health Secretary, Wes Streeting, will look at whether there is an overdiagnosis of ...

MLB drug report shows record-low 54 ADHD exemptions, down from 119 in 2013. Only two PED suspensions in 11,700 tests this season.

A petition has been lodged in the Court of Session amid concerns relating to treatment and assessment procedures.

One of the largest reviews of ADHD treatments to date has analyzed dozens of medications and therapies, revealing that what works best for children often differs sharply from what helps adults.

Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews ...